Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06910436Recruiting

Artificial Intelligence Based Timing, Infarct Size and Outcomes in Acute Coronary Occlusion Myocardial Infarction

Role: lead

NCT06356207Recruiting

Syncope-Asystole Latency Time in Tilt Table Test: The SALT-TILT Study

Role: lead

NCT05851755Enrolling By Invitation

Italian Lung Cancer Observational Study

Role: collaborator

NCT04667286Not ApplicableUnknown

Awake Pronation for Covid-19 Treatment

Role: collaborator

NCT03619460Not ApplicableUnknown

Clinical Efficacy of a New Piezoelectric Technique for Wisdom Teeth Extraction

Role: lead

NCT01526694Phase 2Completed

Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MM

Role: lead

NCT03388203Completed

LC-MS/MS 25(OH)D Status in a Large Cohort

Role: lead

All 7 trials loaded